No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyBrenda Hermsen, Matti A. Rookus, Curt W. Burger et al.|British Journal of Cancer|2007Cited by 153
Reduced local immunity in HPV‐related VIN: Expression of chemokines and involvement of immunocompetent cellsLindy A.M. Santegoets, Leen J. Blok, Manon van Seters et al.|International Journal of Cancer|2008Cited by 29
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the NetherlandsP.M.L.H. Vencken, Caroline Seynaeve, Welmoed Reitsma et al.|Annals of Oncology|2013Cited by 22